Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
fesoterodine 8mg
DRUG
2 trials
Sponsors
Pfizer
, University of Alberta
Conditions
Mild Cognitive Impairment
Overactive Bladder
Phase 2
A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment
Completed
NCT02240459
University of Alberta
Mild Cognitive Impairment, Overactive Bladder
Start: 2016-08-31
End: 2020-01-31
Updated: 2020-02-19
Phase 4
A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
Completed
NCT01302067
Pfizer
Overactive Bladder
Start: 2011-05-31
End: 2012-11-30
Updated: 2014-03-26
Related Papers
A plain language summary of the likelihood of symptom relief for patients taking fesoterodine for overactive bladder.
2022-07-26
1 citations
Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.
2014-07-01
26 citations